Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
1.
J Am Acad Dermatol ; 79(6): 1039-1046, 2018 Dec.
Article in English | MEDLINE | ID: mdl-29928911

ABSTRACT

BACKGROUND: Mycosis fungoides (MF) is the most common cutaneous T-cell lymphoma. Early-stage MF patches or plaques often resemble inflammatory skin disorders (ISDs), including psoriasis and atopic dermatitis. Cell adhesion molecule 1 gene (CADM1), which was initially identified as a tumor suppressor gene in human non-small cell lung cancer, has been reported as a diagnostic marker for adult T-cell leukemia/lymphoma. OBJECTIVE: We investigated CADM1 expression in MF neoplastic cells, especially during early stages, and evaluated its usefulness as a diagnostic marker for MF. METHODS: We conducted a retrospective study by using immunohistochemical staining and confirmed the expression of CADM1 in MF. In addition, we compared CADM1 messenger RNA expression in microdissected MF samples and ISD samples. RESULTS: In the overall study period, 55 of 58 MF samples (94.8 %) stained positive for CADM1. None of the 50 ISD samples showed positive reactivity (P < .0001). We found CADM1 messenger RNA expression in the intradermal lymphocytes of patients with MF but not in those of patients with an ISD. LIMITATIONS: We did not conduct a validation study for MF cases in other institutions. CONCLUSIONS: CADM1-positive cells can be identified in early stages with fewer infiltrating cells and may be useful as a diagnostic marker for early-stage MF.


Subject(s)
Biomarkers, Tumor/analysis , Cell Adhesion Molecule-1/analysis , Mycosis Fungoides/chemistry , Neoplasm Proteins/analysis , Adult , Aged , Aged, 80 and over , Cell Adhesion Molecule-1/biosynthesis , Cell Adhesion Molecule-1/genetics , Dermatitis/metabolism , Early Diagnosis , Female , Gene Expression Regulation, Neoplastic , Humans , Japan/epidemiology , Lymphocytes/metabolism , Lymphocytes/pathology , Middle Aged , Mycosis Fungoides/diagnosis , Mycosis Fungoides/genetics , Mycosis Fungoides/pathology , Neoplasm Proteins/biosynthesis , Neoplasm Proteins/genetics , Neoplasm Staging , RNA, Messenger/biosynthesis , RNA, Neoplasm/biosynthesis , Retrospective Studies
2.
Case Rep Oncol ; 8(3): 536-9, 2015.
Article in English | MEDLINE | ID: mdl-26997948

ABSTRACT

Nevoid basal cell carcinoma syndrome (NBCCS), also known as Gorlin syndrome, is a rare hereditary condition characterized by a wide range of developmental abnormalities and a predisposition to neoplasms. The syndrome consists of early-onset and/or multiple BCC. Herein we report a rare NBCCS case in which the first BCC onset occurred in the groin area. To the best of our knowledge, there have been no reports of first-onset BCC in the groin area in an NBCCS patient of any race.

4.
J Dermatol ; 41(4): 316-8, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24611955

ABSTRACT

To preserve oral function and achieve acceptable cosmetic results, intraoperative control of surgical margins with frozen section evaluation may help to determine surgical technique in lip cancer. However, frozen section analysis is usually limited to suspicious areas and has not been systematically performed among surgeons. The accuracy of such analysis for detecting histological surgical margins is highly dependent on the methods used to obtain and analyze the margins. Improving the pathodiagnostic reliability of conventional intraoperative frozen section evaluation is the most important goal of surgical management in our method. We describe the successful use of the "double-blade method" in lip cancer treatment. The technique we describe has the advantage of histologically confirming clear margins in lip cancer. This method appears to be time-saving and easy to apply with existing surgical systems. In addition, this method may be used as an alternative to complete evaluation of lateral surgical margins that is important in planning a suitable surgical reconstruction procedure in lip cancer at many institutions where Mohs micrographic surgery is difficult to perform.


Subject(s)
Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/surgery , Dermatologic Surgical Procedures/methods , Lip Neoplasms/pathology , Lip Neoplasms/surgery , Aged , Aged, 80 and over , Dermatologic Surgical Procedures/instrumentation , Female , Frozen Sections , Humans , Intraoperative Period , Male , Middle Aged
10.
Oncology ; 82(3): 139-46, 2012.
Article in English | MEDLINE | ID: mdl-22433252

ABSTRACT

OBJECTIVE: To determine the beneficial effect of maintenance therapy in stage II and III melanoma by sequential local injection of low-dose interferon-ß. METHODS: We reviewed 46 patients with stage II and III primary melanoma at our institution from 2004 through 2009. Twenty-one patients were treated with interferon-ß maintenance therapy consisting of subcutaneous injection of natural interferon-ß at a dose of 3 × 10(6) IU/day for 10 consecutive days, and 25 patients underwent observation alone. RESULTS: Compared with all patients, overall survival and relapse-free survival were significantly worse in the observation group than in the interferon-ß group (p = 0.024 and 0.029, respectively). In stage II, a significant difference in overall survival, but not in relapse-free survival, was seen between the two groups (p = 0.041). When the interferon-ß group was stratified by subgroup, there was a statistical difference only between dosage and duration (p = 0.027 and p < 0.001, respectively). CONCLUSIONS: This study demonstrates that maintenance therapy by interferon-ß is beneficial in the outcome of the disease without substantial toxic effects, especially in patients with stage II melanoma. Extension of the duration of treatment beyond 2 years could further improve the therapeutic efficacy of interferon-ß.


Subject(s)
Antineoplastic Agents/administration & dosage , Interferon-beta/administration & dosage , Melanoma/drug therapy , Melanoma/mortality , Skin Neoplasms/drug therapy , Skin Neoplasms/mortality , Aged , Case-Control Studies , Dose-Response Relationship, Drug , Female , Humans , Injections, Subcutaneous , Male , Melanoma/pathology , Neoplasm Staging , Prognosis , Retrospective Studies , Skin Neoplasms/pathology , Survival Rate
12.
Acta Derm Venereol ; 90(2): 165-9, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20169300

ABSTRACT

Recessive dystrophic epidermolysis bullosa (RDEB) is an inherited skin disorder caused by mutations in the COL7A1 gene, which encodes collagen VII (COL7). Skin ulcers in RDEB patients are sometimes slow to heal. We describe here the therapeutic response of intractable skin ulcers in two patients with generalized RDEB to treatment with an allogeneic cultured dermal substitute (CDS). Skin ulcers in both patients epithelialized by 3-4 weeks after this treatment. Immunohistochemical studies demonstrated that the COL7 expression level remained reduced with respect to the control skin and that it did not differ significantly between graft-treated and untreated areas. Electron microscopy showed aberrant anchoring fibrils beneath the lamina densa of both specimens. In conclusion, CDS is a promising modality for treatment of intractable skin ulcers in patients with RDEB, even though it does not appear to increase COL7 expression.


Subject(s)
Dermatologic Surgical Procedures , Epidermolysis Bullosa Dystrophica/surgery , Fibroblasts/transplantation , Skin Transplantation , Skin Ulcer/surgery , Skin, Artificial , Tissue Engineering , Wound Healing , Adult , Cells, Cultured , Collagen Type VII/genetics , Collagen Type VII/metabolism , Epidermolysis Bullosa Dystrophica/genetics , Epidermolysis Bullosa Dystrophica/pathology , Female , Humans , Middle Aged , Mutation , Skin/diagnostic imaging , Skin/metabolism , Skin Ulcer/genetics , Skin Ulcer/pathology , Time Factors , Tissue Scaffolds , Transplantation, Homologous , Treatment Outcome , Ultrasonography
13.
J Surg Oncol ; 101(2): 175-9, 2010 Feb 01.
Article in English | MEDLINE | ID: mdl-20082361

ABSTRACT

BACKGROUND: In some countries, intraoperative histological evaluation to control the surgical margin for non-melanoma skin cancer is widely used instead of Mohs micrographic surgery. Nevertheless, this evaluation by frozen section analysis is usually limited to suspicious areas. OBJECTIVES: To evaluate the efficacy of double-bladed scalpel for intraoperative histological margin control for non-melanoma skin cancers. METHODS: Between 2005 and 2009, 10 basal cell carcinomas and 5 squamous cell carcinomas were underwent complete histological margin control in which a double-bladed scalpel was used during the surgery at the Hokkaido University Hospital in Japan. RESULTS: The mean number of re-excisions required for complete tumor resection was 1.4 times. Nine (60%) of the 15 patients obtained histological clearance of all surgical margins at the first re-excision. The mean size of total surgical margin was 6.1 mm (range: 2-12 mm). The median time from the first tumor excision to reconstruction was 124 min. No local recurrences have been reported. CONCLUSIONS: This method may be used as an alternative for complete histological margin control at many hospitals where it is difficult to perform Mohs micrographic surgery.


Subject(s)
Carcinoma, Basal Cell/pathology , Carcinoma, Squamous Cell/pathology , Skin Neoplasms/pathology , Aged , Aged, 80 and over , Carcinoma, Basal Cell/surgery , Carcinoma, Squamous Cell/surgery , Female , Humans , Male , Middle Aged , Skin Neoplasms/surgery
16.
J Am Acad Dermatol ; 57(3): 523-6, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17599665

ABSTRACT

Amicrobial pustulosis is a rare clinical entity characterized by a relapsing pustular eruption, primarily involving the skin folds. We describe a case of amicrobial pustulosis associated with autoimmune diseases (APAD). The patient suffered from IgA nephropathy and Sjögren's syndrome. Skin symptoms were alleviated dramatically after corticosteroid pulse therapy and tonsillectomy.


Subject(s)
Glomerulonephritis, IGA/complications , Sjogren's Syndrome/complications , Skin Diseases, Vesiculobullous/complications , Skin Diseases, Vesiculobullous/therapy , Adrenal Cortex Hormones/therapeutic use , Adult , Humans , Male , Pulse Therapy, Drug , Skin Diseases, Vesiculobullous/pathology , Tonsillectomy , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL